The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.22BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Trailing P/E
37.35x
Updated Oct 27, 2026
Revenue (TTM)
737.20MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Profit Margin
8.91%
Updated Oct 27, 2026
Beta
2.48x
vs all stocks
Updated Oct 27, 2026
52-Week Change
-7.07%
vs all stocks
Updated Oct 27, 2026
Market Capitalization
2.22BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Enterprise Value
2.22BUSD
vs all stocks (USD)
Updated Oct 27, 2026
Trailing P/E
37.35x
Updated Oct 27, 2026
Forward P/E
7.23x
Updated Oct 27, 2026
PEG Ratio
-0.0902x
Updated Oct 27, 2026
Price to Sales (TTM)
3.00x
Updated Oct 27, 2026
Price to Book (MRQ)
3.10x
Updated Oct 27, 2026
Enterprise to Revenue
3.01x
Updated Oct 27, 2026
Enterprise to EBITDA
7.88x
Updated Oct 27, 2026
Gross Margin
34.84%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 44.09%.Updated Oct 27, 2026
Profit Margin
8.91%
Updated Oct 27, 2026
Operating Margin
30.50%
Updated Oct 27, 2026
Return on Assets (TTM)
10.13%
Updated Oct 27, 2026
Return on Equity (TTM)
10.58%
Updated Oct 27, 2026
Revenue (TTM)
737.20MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Revenue per Share (TTM)
2.50USDUpdated Oct 27, 2026
Quarterly Revenue Growth
139.40%
Updated Oct 27, 2026
Gross Profit (TTM)
325.00MUSD
vs all stocks (USD)
Updated Oct 27, 2026
EBITDA (TTM)
280.62MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Net Income (TTM)
65.70MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Operating Cash Flow (TTM)
103.10MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Levered Free Cash Flow (TTM)
67.66MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Payout Ratio
0.00%
Updated Oct 27, 2026
Revenue
467.50MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
385.10MUSDFY2025 · Dec 31, 2025
Gross Profit
82.40MUSDFY2025 · Dec 31, 2025
Operating Income
38.50MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-104.90MUSDFY2025 · Dec 31, 2025
Income Tax Expense
14.20MUSDFY2025 · Dec 31, 2025
Net Income
-119.10MUSDFY2025 · Dec 31, 2025
EBIT
-98.60MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
112.30MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
19.30MUSDFY2025 · Dec 31, 2025
Other Operating Expenses
24.60MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
6.30MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-0.4200USDFY2025 · Dec 31, 2025
EPS (Diluted)
-0.4200USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
283.08MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
283.08MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-119.10MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-42.60MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-211.80MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
223.70MUSDFY2025 · Dec 31, 2025
Income Tax Paid
22.20MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-119.10MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
73.80MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
-22.40MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
3.90MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
26.60MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-43.50MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
58.00MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-19.90MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-169.20MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-72.10MUSDFY2025 · Dec 31, 2025
Sale of Investments
800.00KUSDFY2025 · Dec 31, 2025
Other Investing Activity
200.00KUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-240.30MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
354.10MUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-160.60MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
31.50MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
295.50MUSDFY2025 · Dec 31, 2025
Shares Outstanding
296.14MSharesUpdated Oct 27, 2026
Float Shares
295.59MSharesUpdated Oct 27, 2026
Shares Short
21.84MSharesUpdated Oct 27, 2026
Short Ratio
2.62days
vs all stocks
Updated Oct 27, 2026
% Held by Insiders
0.16%
vs all stocks
Updated Oct 27, 2026
% Held by Institutions
58.84%
vs all stocks
Updated Oct 27, 2026
Total Cash (MRQ)
243.40MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Cash per Share (MRQ)
0.8220USDUpdated Oct 27, 2026
Total Debt (MRQ)
248.20MUSD
vs all stocks (USD)
Updated Oct 27, 2026
Total Debt to Equity (MRQ)
0.3484x
Updated Oct 27, 2026
Current Ratio (MRQ)
1.97x
Updated Oct 27, 2026
Book Value per Share (MRQ)
2.41USDUpdated Oct 27, 2026
Total Assets
1.24BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
423.20MUSDFY2025 · Dec 31, 2025
Total Liabilities
656.60MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
812.50MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
379.80MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
276.80MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
215.40MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
1.00MUSDFY2025 · Dec 31, 2025
Accounts Receivable
20.60MUSDFY2025 · Dec 31, 2025
Inventory
62.30MUSDFY2025 · Dec 31, 2025
Accounts Payable
120.40MUSDFY2025 · Dec 31, 2025
Short-term Debt
8.80MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
123.30MUSDFY2025 · Dec 31, 2025
Long-term Debt
235.00MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
48.10MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
981.20MUSDFY2025 · Dec 31, 2025
Retained Earnings
-491.30MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
579.10MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
6.60USDUpdated Oct 27, 2026
52-Week High
15.15USDUpdated Oct 27, 2026
52-Week Change
-7.07%
vs all stocks
Updated Oct 27, 2026
Beta
2.48x
vs all stocks
Updated Oct 27, 2026
50-Day MA
9.61USDUpdated Oct 27, 2026
200-Day MA
9.84USDUpdated Oct 27, 2026
Avg 10-Day Volume
5.92MSharesUpdated Oct 27, 2026
Avg 30-Day Volume
6.82MSharesUpdated Oct 27, 2026
Diluted EPS (TTM)
0.2000USDUpdated Oct 27, 2026
Other Income / Expense
-137.10MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 1.73: grey zoneSignificant
Altman Z-Score: 1.73
High earnings qualityNotable
Earnings Quality Score: 0.66
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $2.22B, above the global median of $1.14BNotable
Market cap (USD): 2,218,122,147Global Median: 1,137,180,293.291
Revenue is $737.2M, above the global median of $566.17MNotable